The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease. [electronic resource]
Producer: 20041013Description: 281-324 p. digitalISSN:- 1699-3993
- Animals
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Clinical Trials as Topic
- Cost-Benefit Analysis
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Etanercept
- Humans
- Immunoglobulin G -- administration & dosage
- Methotrexate -- administration & dosage
- Quality of Life
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Recombinant Fusion Proteins -- therapeutic use
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.